Ubiquitin-like modifier-activating enzyme 2 (UBA2) is an important member of the SUMO modification system; however, its role in clear cell renal cell carcinoma (ccRCC) is unclear. This evidence concerns the gene UBA2 and nonpapillary renal cell carcinoma.